[go: up one dir, main page]

GB2437681B - Methods of identifying modulators of CFTR/CK2 interaction - Google Patents

Methods of identifying modulators of CFTR/CK2 interaction

Info

Publication number
GB2437681B
GB2437681B GB0715741A GB0715741A GB2437681B GB 2437681 B GB2437681 B GB 2437681B GB 0715741 A GB0715741 A GB 0715741A GB 0715741 A GB0715741 A GB 0715741A GB 2437681 B GB2437681 B GB 2437681B
Authority
GB
United Kingdom
Prior art keywords
cftr
interaction
methods
identifying modulators
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0715741A
Other versions
GB0715741D0 (en
GB2437681A (en
Inventor
Anil Mehta
Russell Crawford
Kathryn Treharne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0500607A external-priority patent/GB0500607D0/en
Priority claimed from GB0507463A external-priority patent/GB0507463D0/en
Application filed by University of Dundee filed Critical University of Dundee
Publication of GB0715741D0 publication Critical patent/GB0715741D0/en
Publication of GB2437681A publication Critical patent/GB2437681A/en
Application granted granted Critical
Publication of GB2437681B publication Critical patent/GB2437681B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/382—Cystic fibrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
GB0715741A 2005-01-13 2007-08-13 Methods of identifying modulators of CFTR/CK2 interaction Expired - Fee Related GB2437681B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500607A GB0500607D0 (en) 2005-01-13 2005-01-13 Methods
GB0507463A GB0507463D0 (en) 2005-04-13 2005-04-13 Methods
PCT/GB2006/000122 WO2006075172A2 (en) 2005-01-13 2006-01-13 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2

Publications (3)

Publication Number Publication Date
GB0715741D0 GB0715741D0 (en) 2007-09-19
GB2437681A GB2437681A (en) 2007-10-31
GB2437681B true GB2437681B (en) 2009-10-21

Family

ID=36371733

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0715741A Expired - Fee Related GB2437681B (en) 2005-01-13 2007-08-13 Methods of identifying modulators of CFTR/CK2 interaction

Country Status (2)

Country Link
GB (1) GB2437681B (en)
WO (1) WO2006075172A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
US9447458B2 (en) 2011-11-16 2016-09-20 Canon U.S. Life Sciences, Inc. Detection of neighboring variants
WO2023167516A1 (en) * 2022-03-03 2023-09-07 숙명여자대학교 산학협력단 Novel 2-(phenylamino)pyridine-based tead inhibitor and pharmaceutical composition comprising same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005273A1 (en) * 1990-09-18 1992-04-02 The Regents Of The University Of Michigan Gene therapy for cystic fibrosis
US20010041685A1 (en) * 2000-01-31 2001-11-15 Yuhong Zhou Mucin synthesis inhibitors
US6620795B1 (en) * 1991-12-17 2003-09-16 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
WO2003087389A2 (en) * 2002-04-08 2003-10-23 Genesegues, Inc. Biologic modulations with nanoparticles
US20040121968A1 (en) * 2002-12-23 2004-06-24 Alexander Ljubimov Antiangiogenesis by inhibiting protein kinase CK2 activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005273A1 (en) * 1990-09-18 1992-04-02 The Regents Of The University Of Michigan Gene therapy for cystic fibrosis
US6620795B1 (en) * 1991-12-17 2003-09-16 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US20010041685A1 (en) * 2000-01-31 2001-11-15 Yuhong Zhou Mucin synthesis inhibitors
WO2003087389A2 (en) * 2002-04-08 2003-10-23 Genesegues, Inc. Biologic modulations with nanoparticles
US20040121968A1 (en) * 2002-12-23 2004-06-24 Alexander Ljubimov Antiangiogenesis by inhibiting protein kinase CK2 activity

Also Published As

Publication number Publication date
WO2006075172A3 (en) 2006-09-14
GB0715741D0 (en) 2007-09-19
WO2006075172A2 (en) 2006-07-20
GB2437681A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
GB0522477D0 (en) Modulator
ZA201005380B (en) Boron-containing small molecules
IL192402A0 (en) Boron-containing small molecules
EP1958024A4 (en) ENHANCED SCREEN MODULATION TECHNIQUES
ZA200808410B (en) Pyrrolo-and thiazolo-pyridine compounds as hif modulators
IL182139A0 (en) MODIFIED Fc MOLECULES
IL206502A0 (en) Methods for using and identifying modulators of delta-like 4
IL189846A0 (en) Theramutein modulators
GB0602384D0 (en) Optical modulator
EP1841794A4 (en) ADAM-9 MODULATORS
EP1868025A4 (en) Optical modulator
IL187692A0 (en) Alkylquinoline and alkylquinazoline kinase modulators
IL198352A0 (en) Modulators of neuronal regeneration
EP1901109A4 (en) Optical modulator
IL176693A0 (en) Stable suspensions containing microcapsules and methods for the preparation thereof
ZA200805241B (en) Heterocyclic GABAB modulators
EP1916563A4 (en) Optical modulator
EP1915162A4 (en) MODULATORS
DK2447252T3 (en) Theramutein modulators
EP2015129A4 (en) Optical modulator
EP1950602A4 (en) OPTICAL MODULATOR
GB2437681B (en) Methods of identifying modulators of CFTR/CK2 interaction
DE602006011753D1 (en) SIGMA-DELTA MODULATORS
EP1966603A4 (en) Binding of molecules
EP1953584A4 (en) Optical modulator

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120113